Gelesis Holdings Total Liabilities 2021-2022 | GLS
Gelesis Holdings total liabilities from 2021 to 2022. Total liabilities can be defined as the total value of all possible claims against the corporation.
Gelesis Holdings Annual Total Liabilities
(Millions of US $) |
| 2021 |
$330 |
| 2020 |
$317 |
| 2019 |
$ |
Gelesis Holdings Quarterly Total Liabilities
(Millions of US $) |
| 2022-03-31 |
$143 |
| 2021-12-31 |
$476 |
| 2021-09-30 |
$321 |
| 2021-06-30 |
$272 |
| 2021-03-31 |
$272 |
| 2020-12-31 |
|
| 2020-09-30 |
$272 |
| 2020-06-30 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.114B |
$0.011B |
|
Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Gelesis, formerly known as Capstar Special Purpose Acquisition Corp., is based in BOSTON.
|
